Literature DB >> 12831396

Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin.

Dragos Vinereanu1, Eleftherios Nicolaides, Ann C Tweddel, Christoph F Mädler, Ben Holst, Lucy E Boden, Mircea Cinteza, Alan E Rees, Alan G Fraser.   

Abstract

The aim of the present study was to measure regional ventricular function at rest and during stress in order to assess if patients with Type II diabetes have subclinical myocardial dysfunction and if it is related to risk factors. Seventy subjects (35 patients with Type II diabetes with no symptoms, signs or history of heart disease, and 35 age- and sex-matched healthy controls) had echocardiography at rest and during dobutamine stress. Myocardial velocities were measured off-line from digital loops of colour tissue Doppler. Subendocardial function was assessed from the mean longitudinal velocities of four basal segments (apical views) and radial function from the velocities of the basal posterior wall (parasternal view). Systolic functional reserve was calculated as the increase in velocity from baseline. Longitudinal peak systolic velocity was lower in patients with diabetes, at rest (5.6 +/- 1.4 compared with 6.5 +/- 1.1 cm/s) and at peak stress (10.9 +/- 2.8 compared with 14.3 +/- 2.1 cm/s) (both P <0.01). Functional reserve was impaired in patients with diabetes (+5.4 +/- 2.0 compared with +7.7 +/- 1.7 cm/s; P <0.01). Radial systolic velocity was higher in patients with diabetes (5.4 +/- 1.3 compared with 4.7 +/- 1.4 cm/s; P <0.05). Resting longitudinal systolic function correlated inversely with low-density lipoprotein-cholesterol ( r =-0.53), glycated haemoglobin ( r =-0.48), age ( r =-0.41) and diastolic blood pressure ( r =-0.38) (all P < 0.05). Peak stress systolic velocity correlated inversely with glycated haemoglobin ( r =-0.46) and age ( r =-0.44) (both P < 0.01). In conclusion, patients with Type II diabetes and no clinical heart disease have impaired subendocardial function of the left ventricle at rest and peak stress, which is related to glycated haemoglobin and serum low-density lipoprotein-cholesterol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12831396     DOI: 10.1042/CS20030168

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  44 in total

Review 1.  Diabetic heart disease.

Authors:  T H Marwick
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Identification of diabetic cardiomyopathy with cardiac magnetic resonance imaging.

Authors:  Thomas H Marwick
Journal:  Int J Cardiovasc Imaging       Date:  2006-02       Impact factor: 2.357

3.  Impaired myocardial oxidative metabolism in the remote normal region in patients in the chronic phase of myocardial infarction and left ventricular remodeling.

Authors:  Nobuyuki Ohte; Hitomi Narita; Akihiko Iida; Kazuaki Wakami; Kaoru Asada; Hidekatsu Fukuta; Takafumi Kato; Junichiro Hyano; Genjiro Kimura
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

4.  Left ventricular remodeling after myocardial infarction impairs early diastolic, but not systolic, function in the radial direction in the remote normal region.

Authors:  Hiroko Kobayakawa; Nobuyuki Ohte; Kazuaki Wakami; Hidekatsu Fukuta; Toshihiko Goto; Tomomitsu Tani; Hitomi Narita; Genjiro Kimura
Journal:  J Echocardiogr       Date:  2010-07-31

Review 5.  The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions.

Authors:  J Chris Baldi; Genevieve A Wilson; Luke C Wilson; Gerard T Wilkins; Regis R Lamberts
Journal:  Sports Med       Date:  2016-11       Impact factor: 11.136

6.  The relationship between arterial wall stiffness and left ventricular dysfunction.

Authors:  Y Hu; L Li; L Shen; H Gao
Journal:  Neth Heart J       Date:  2013-05       Impact factor: 2.380

7.  Global myocardial perfusion and diastolic function are impaired to a similar extent in patients with type 2 diabetes mellitus and in patients with coronary artery disease--evaluation by contrast echocardiography and pulsed tissue Doppler.

Authors:  V Dounis; T Siegmund; A Hansen; J Jensen; P-M Schumm-Draeger; H von Bibra
Journal:  Diabetologia       Date:  2006-09-21       Impact factor: 10.122

8.  Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Authors:  Karina Huynh; Julie R McMullen; Tracey L Julius; Joon Win Tan; Jane E Love; Nelly Cemerlang; Helen Kiriazis; Xiao-Jun Du; Rebecca H Ritchie
Journal:  Diabetes       Date:  2010-03-09       Impact factor: 9.461

9.  Lack of effects of pioglitazone on cardiac function in patients with type 2 diabetes and evidence of left ventricular diastolic dysfunction: a tissue doppler imaging study.

Authors:  Katerina K Naka; Konstantinos Pappas; Katerina Papathanassiou; Nikolaos D Papamichael; Nikolaos Kazakos; Chryssanthi Kanioglou; Demetrios Makriyiannis; Christos S Katsouras; Kostas Liveris; Agathocles Tsatsoulis; Lampros K Michalis
Journal:  Cardiovasc Diabetol       Date:  2010-09-23       Impact factor: 9.951

Review 10.  Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

Authors:  Christina Voulgari; Dimitrios Papadogiannis; Nicholas Tentolouris
Journal:  Vasc Health Risk Manag       Date:  2010-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.